Results 121 to 130 of about 1,704,994 (242)

Clinical Characteristics of Over‐The‐Counter Drug Misusers in Psychiatric Practice in Japan: Comparison by Type of Drug Misused for the First Time

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
OTC drug misuse has become a significant public health concern among adolescent females in Japan. ABSTRACT Purpose This study aimed to understand the clinical characteristics of individuals who misuse over‐the‐counter (OTC) drugs in psychiatric clinical settings in Japan, and to reconsider approaches to current drug misuse prevention education and ...
Soichiro Omiya, Yuko Tanibuchi, Takashi Usami, Takuya Shimane, Toshihiko Matsumoto   +4 more
wiley   +1 more source

Sex Difference in Effect of the OPRM1 Gene A118G (rs1799971) Single‐Nucleotide Polymorphism on the Requirement for Postoperative Fentanyl in Japanese Patients Who Underwent Laparoscopic‐Assisted Colectomy

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
This study found that the OPRM1 A118G polymorphism was associated with sex‐specific differences in pain and opioid sensitivity among Japanese patients, highlighting a potential role of genotype‐by‐sex interaction in personalized pain management. ABSTRACT Background The A118G (rs1799971) single‐nucleotide polymorphism (SNP) of the OPRM1 gene, which ...
Hideyuki Nakagawa, Daisuke Nishizawa, Tsutomu Mieda, Miki Tsujita, Shinya Kasai, Junko Hasegawa, Kyoko Nakayama, Yuko Ebata, Akira Kitamura, Masakazu Hayashida, Kazutaka Ikeda   +10 more
wiley   +1 more source

Insurance Coverage and Provision of Opioid Disorder Treatment: Evidence From Medicare

Journal of Policy Analysis and Management, Volume 45, Issue 3, Summer 2026.
ABSTRACT Older adult opioid overdose deaths have increased over the past two decades in the United States. Methadone, one of three medications approved for opioid use disorder (OUD) treatment, was not covered by Medicare—the primary insurer of Americans 65 years and older—for OUD until 2020.
Denis Agniel, Jonathan Cantor, Johanna Catherine Maclean, Erin A. Taylor, Kosali Simon   +4 more
wiley   +1 more source

Analytically Confirmed Opioid Detections From the Emerging Drugs Network of Australia

Emergency Medicine Australasia, Volume 38, Issue 3, June 2026.
ABSTRACT Objective We describe analytically confirmed opioid‐related presentations to emergency departments (EDs) in Australia. Methods Presentations with analytically confirmed opioid exposure, between January 2021 and December 2024, were identified from the Emerging Drugs Network of Australia (EDNA) Clinical Registry.
J. Soderstrom, C. Weber, S. Greene, K. Isoardi, S. Alfred, V. Tran, P. Stockham, J. Schumann, A. Thompson, D. Fatovich, on behalf of the EDNA Investigators, Jessamine Soderstrom, Jennifer Smith, Daniel Fatovich, Shaun Greene, Sam Alfred, Katherine Isoardi, Andrew Dawson, Anthony Tzannes, Hugh Mitenko, Hwee Min Lee, Kirsty Skinner, Viet Tran, Ben Weber, Vanessa Shaw, Timothy Cook, Courtney Weber, Sharon Waterson, David McCutcheon, Natalie MacCormick, Keith Harris, Francois Oosthuizen, Peter Stockham, Dimitri Gerostamoulos, Andis Graudins, Una Nic Ionmhain, Christopher Reid, Paul Dessauer, Andrew Kozman, Mohan Raghavan, Ellie Kotkis, Craig Gardner, Giles Barrington, Jason White, Samantha Carey, Jennifer Schumann, Eden Smyth, Owen McWilliam, Jolanda Nijmeijer, Elyssia Bourke, Craig Cumming, Thanjira Jiranantakan, Abigail Stafslien‐Dumale, Maurizio Stefani   +53 more
wiley   +1 more source

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada

Addiction, Volume 121, Issue 6, Page 1530-1540, June 2026.
Abstract Background and aims Canada's drug toxicity crisis has been largely attributed to a volatile fentanyl‐dominated unregulated drug supply with increasing reports of fentanyl detected in combination with benzodiazepines, stimulants and xylazine.
Shaleesa Ledlie, Ria Garg, Pamela Leece, Gillian Kolla, Elaine Hyshka, Mina Tadrous, Tara Gomes   +6 more
wiley   +1 more source

Study of the Transition from Non-Injection to Injection in Heroin Users

پزشکی بالینی ابن سینا, 2010
Introduction & Objectives: The goal of our study was to elucidate the time and factors influencing the transition from non-injection to injection among male heroin users.
Mosaieb Yarmohammadi Vasel, Fatemeh Ghanadi   +1 more
doaj  

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, Volume 121, Issue 6, Page 1616-1621, June 2026.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

Addiction, Volume 121, Issue 6, Page 1541-1556, June 2026.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu, Chia‐Chun Hung, Marc N. Potenza, Kun‐Hsien Chou, Pei‐Lin Lee, Chu‐Chung Huang, Chiang‐Shan R. Li, Tony Szu‐Hsien Lee, Ching‐Po Lin   +8 more
wiley   +1 more source

Relationship Between Buddhist Belief and Suicide Risk in Chinese Persons Undergoing Methadone Maintenance Therapy for Heroin Dependence. [PDF]

Front Psychiatry, 2020
Huang JX, Xu YM, Zhong BL.
europepmc   +1 more source